Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03340454 · ClinicalTrials.gov registry record · NA
Patient-Centered Cancer Prevention In Chinese Americans
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 135
- Enrollment target
NCT03340454 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 135 participants.
The verdict
NCT03340454, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 135 participants
- Enrollment target
Study Summary
This study will assess the efficacy, adoption, and impact of an integrated intervention to improve adherence to recommended stomach cancer prevention guidelines (H. pylori test-and-treat) for at-risk Chinese Americans in NYC. The integrated multifaceted theory-based intervention involves: 1) a health systems-level intervention using electronic health record (EHR)-based tools to facilitate H. pylori test-and-treat strategies; and 2) a community-engaged culturally and linguistically adapted CHW-led patient navigation program we are currently pilot testing for feasibility and acceptability. Using a 2-arm randomized controlled trial (RCT) design, \> 144 Chinese American patients across NYC safety net hospital endoscopy clinics and primary health centers will participate.
Interventions
- OTHER Test-and-treat EHR-CHW intervention
- OTHER Usual care of EHR-only intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2018-08-15 |
| Est. Completion | 2023-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03340454
The ClinicalTrials.gov registry entry for NCT03340454 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Test-and-treat EHR-CHW intervention is the first listed.
NCT03340454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03340454 about?
NCT03340454 is a clinical study titled "Patient-Centered Cancer Prevention In Chinese Americans". This study will assess the efficacy, adoption, and impact of an integrated intervention to improve adherence to recommended stomach cancer prevention guidelines (H. pylori test-and-treat) for at-risk Chinese Americans in NYC. The integrated multifaceted theory-based intervention involves: 1) a healt...
What is the current status of trial NCT03340454?
This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2018-08-15. Estimated completion is 2023-06-15.
What interventions are being tested in trial NCT03340454?
The interventions under investigation include: Test-and-treat EHR-CHW intervention (OTHER), Usual care of EHR-only intervention (OTHER).
Who is sponsoring clinical trial NCT03340454?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.